These results provide data supporting the future use of the hRO-AMD model to reveal the mechanisms involved in the regulation of HMOX1 expression during AMD pathogenesis, to screen small molecule compounds that target HMOX1 and its downstream pathway activation, and to explore new therapies for the treatment of human dry AMD. The gene discussed is HMOX1; the disease is age-related macular degeneration.